巨細胞動脈炎:治療薬のグローバル治験動向(2014年下半期)

◆英語タイトル:Giant Cell Arteritis Global Clinical Trials Review, H2, 2014
◆発行会社/調査会社:GlobalData
◆商品コード:GDHC2330CTIDB
◆発行日:2014年9月10日
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆ページ数:70
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥555,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥832,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の市場調査資料のご購入、委託調査サービスに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[巨細胞動脈炎:治療薬のグローバル治験動向(2014年下半期)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Giant Cell Arteritis Global Clinical Trials Review, H2, 2014

Summary

GlobalData’s clinical trial report, “Giant Cell Arteritis Global Clinical Trials Review, H2, 2014″ provides data on the Giant Cell Arteritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Giant Cell Arteritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Giant Cell Arteritis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

*** レポート目次(コンテンツ)***

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Giant Cell Arteritis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Giant Cell Arteritis to Cardiovascular Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Giant Cell Arteritis to Cardiovascular Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Unaccomplished Trials of Giant Cell Arteritis 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Giant Cell Arteritis Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
F. Hoffmann-La Roche Ltd. 28
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 28
Laboratorios Servier, S.L. 29
Clinical Trial Overview of Laboratorios Servier, S.L. 29
Janssen Global Services, LLC 30
Clinical Trial Overview of Janssen Global Services, LLC 30
Clinical Trial Overview of Top Institutes / Government 31
University of Oxford 31
Clinical Trial Overview of University of Oxford 31
Centre Hospitalier Universitaire Dijon 32
Clinical Trial Overview of Centre Hospitalier Universitaire Dijon 32
Japan Intractable Diseases Research Foundation 33
Clinical Trial Overview of Japan Intractable Diseases Research Foundation 33
FDA Office of Orphan Products Development 34
Clinical Trial Overview of FDA Office of Orphan Products Development 34
Saitama Medical University 35
Clinical Trial Overview of Saitama Medical University 35
University of Bern 36
Clinical Trial Overview of University of Bern 36
Caen University Hospital 37
Clinical Trial Overview of Caen University Hospital 37
University Hospital, Toulouse 38
Clinical Trial Overview of University Hospital, Toulouse 38
University of Pennsylvania 39
Clinical Trial Overview of University of Pennsylvania 39
National Institute of Arthritis and Musculoskeletal and Skin Diseases 40
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 40
Five Key Clinical Profiles 41
Appendix 68
Abbreviations 68
Definitions 68
Research Methodology 69
Secondary Research 69
About GlobalData 70
Contact Us 70
Disclaimer 70
Source 70

List of Tables
Giant Cell Arteritis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Giant Cell Arteritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Giant Cell Arteritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Giant Cell Arteritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Giant Cell Arteritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Giant Cell Arteritis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Giant Cell Arteritis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Giant Cell Arteritis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 14
Giant Cell Arteritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Giant Cell Arteritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Giant Cell Arteritis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 17
Giant Cell Arteritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Giant Cell Arteritis Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Giant Cell Arteritis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Giant Cell Arteritis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Giant Cell Arteritis Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Giant Cell Arteritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Giant Cell Arteritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Giant Cell Arteritis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Giant Cell Arteritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Giant Cell Arteritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 28
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratorios Servier, S.L., 2014* 29
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2014* 30
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014* 31
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire Dijon, 2014* 32
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Intractable Diseases Research Foundation, 2014* 33
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by FDA Office of Orphan Products Development, 2014* 34
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2014* 35
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Bern, 2014* 36
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Caen University Hospital, 2014* 37
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Toulouse, 2014* 38
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014* 39
Giant Cell Arteritis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2014* 40

List of Figures
Giant Cell Arteritis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Giant Cell Arteritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Giant Cell Arteritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Giant Cell Arteritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Giant Cell Arteritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Giant Cell Arteritis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Giant Cell Arteritis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 14
Giant Cell Arteritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Giant Cell Arteritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Giant Cell Arteritis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 17
Giant Cell Arteritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Giant Cell Arteritis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Giant Cell Arteritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Giant Cell Arteritis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Giant Cell Arteritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Giant Cell Arteritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Giant Cell Arteritis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Giant Cell Arteritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Giant Cell Arteritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 69

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※H&Iグローバルリサーチは調査サービスを通じて、お客様の海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをご提供しております。
※当市場調査資料"巨細胞動脈炎:治療薬のグローバル治験動向(2014年下半期)"は"GlobalData社"が調査・発行しており、H&Iグローバルリサーチが販売します。お気軽にお問い合わせください。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。